PREFERRED STOCK	3 Months Ended
Mar. 31, 2026
Equity [Abstract]
PREFERRED STOCK	13. PREFERRED STOCK In March 2026, the Company issued 30,000 shares of Series B Non-Cumulative Perpetual Convertible Preferred Stock (the “Series B Preferred Stock”) to an institutional investor raising $30.0 million in capital. The Company has the ability to issue, at its sole discretion, up to 20,000 additional shares to that same investor for $20.0 million through December 31, 2027. The Series B Preferred Stock is convertible into common stock at the option of the holder on any date following the five-year anniversary of the original issue date, subject to applicable terms and conditions. Conversion occurs at a fixed rate of 26.3157 shares of common stock for each share of Series B Preferred Stock held. The Series B Preferred Stock carries a dividend rate of 6.00 percent per annum, is non-callable for the first five years, but may be redeemed on any date thereafter. These securities qualify as Tier 1 Capital for purposes of calculating regulatory capital ratios.

PREFERRED STOCK

3 Months Ended

Mar. 31, 2026

13. PREFERRED STOCK

In March 2026, the Company issued 30,000 shares of Series B Non-Cumulative Perpetual Convertible Preferred Stock (the “Series B Preferred Stock”) to an institutional investor raising $30.0 million in capital. The Company has the ability to issue, at its sole discretion, up to 20,000 additional shares to that same investor for $20.0 million through December 31, 2027. The Series B Preferred Stock is convertible into common stock at the option of the holder on any date following the five-year anniversary of the original issue date, subject to applicable terms and conditions. Conversion occurs at a fixed rate of 26.3157 shares of common stock for each share of Series B Preferred Stock held. The Series B Preferred Stock carries a dividend rate of 6.00 percent per annum, is non-callable for the first five years, but may be redeemed on any date thereafter. These securities qualify as Tier 1 Capital for purposes of calculating regulatory capital ratios.